Metabolic syndrome among people living with HIV on antiretroviral therapy in Mwanza, Tanzania

BACKGROUND: HIV and antiretroviral drugs, particularly protease inhibitors and nucleoside reverse transcriptase inhibitors, may increase the risk of Metabolic Syndrome (MetS) among people living with HIV (PLHIV). However, following the introduction of better drugs like dolutegravir, data on the burd...

Descripción completa

Detalles Bibliográficos
Autores principales: Malindisa, Evangelista, Balandya, Emmanuel, Njelekela, Marina, Kidenya, Benson R., Francis, Filbert, Mmbaga, Blandina T., Dika, Haruna, Lyamuya, Eligius, Sunguya, Bruno, Bartlett, John, PrayGod, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120112/
https://www.ncbi.nlm.nih.gov/pubmed/37085806
http://dx.doi.org/10.1186/s12902-023-01340-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120112/
https://www.ncbi.nlm.nih.gov/pubmed/37085806
http://dx.doi.org/10.1186/s12902-023-01340-3

Ejemplares similares